Anti-IgE monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review

Mostrar otras versiones (1)

BACKGROUND: Several options are available for the treatment of chronic rhinosinusitis (CRS), but disease control remains elusive for many patients. Recently, literature has emerged describing anti-IgE monoclonal antibody as a potential therapy for CRS. However, its effectiveness and safety are not w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Chris J., Tsang, Adrian C., Quinn, Jason G., Bonaparte, James P., Stevens, Adrienne, Kilty, Shaun J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652338/
https://www.ncbi.nlm.nih.gov/pubmed/26581392
http://dx.doi.org/10.1186/s13643-015-0157-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652338/
https://www.ncbi.nlm.nih.gov/pubmed/26581392
http://dx.doi.org/10.1186/s13643-015-0157-5

Ejemplares similares